Lupin LimitedNSE: LUPIN

Press Release Jul 01 2021

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated July 01, 2021, titled "Lupin Announces FDA Approval of Supplemental New Drug Application forSOLOSEC�� (secnidazole) for the Treatment of Trichomoniasis.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases